International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 6 Issue 6 November-December 2024 Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 6 Issue 6
November-December 2024

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Review On Omicron Variant (B.1.1.529) of SARS-CoV2

Author(s) S.U.Salma, P. Akhila, P. Ruchitha, S. Pushpa sree, Dr. V. Jaya Sankar Reddy, Dr. K.T.Naik
Country India
Abstract The virus that causes COVID-19 is called SARS-CoV-2, and it has an Omicron variant. It is the most recent COVID-19 version. This variety, known as omicron, was initially reported to the WHO on November 24, 2021, from South Africa. The WHO's Technical Advisory Group on Virus Evolution (TAG-VE) identified PANGO lineage B.1.1.529. with the Greek letter omicron and declared it a variety of concern on November 261. Omicron possesses multiple mutations that could affect its behaviour, including the degree of disease severity and its transmissibility1. Omicron is thought to be more contagious than its predecessors, spreading around 70 times as quickly18. The omicron variety is found in numerous nations worldwide2. Omicron will therefore not be a final variant, but it may be the final Variant Of Concern (VOC) 8. Numerous spike protein mutations linked to enhanced infectivity and antibody evasion are also present in other variations of concern. According to computational modelling, the variation might also be able to evade cell-mediated immunity23. By sufficiently changing its chemical structure to avoid identification by the immune system, SARS-CoV-2 can evade the immune system8.
Keywords Omicron, SARS-CoV-2, Mutations, Variants
Field Biology > Medical / Physiology
Published In Volume 6, Issue 2, March-April 2024
Published On 2024-04-30
Cite This Review On Omicron Variant (B.1.1.529) of SARS-CoV2 - S.U.Salma, P. Akhila, P. Ruchitha, S. Pushpa sree, Dr. V. Jaya Sankar Reddy, Dr. K.T.Naik - IJFMR Volume 6, Issue 2, March-April 2024. DOI 10.36948/ijfmr.2024.v06i02.18837
DOI https://doi.org/10.36948/ijfmr.2024.v06i02.18837
Short DOI https://doi.org/gts4sj
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 6 Isu 6Cover Page Vol 6 Isu 5Cover Page Vol 6 Isu 4

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9898-5948-55 editor@ijfmr.com